Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy

Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy—A Rare Event

Published:2021-12-01 Issue:12 Volume:7 Page:1851
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Barrio Andrea V.¹,Montagna Giacomo¹,Mamtani Anita¹,Sevilimedu Varadan²,Edelweiss Marcia³,Capko Deborah¹,Cody Hiram S.¹,El-Tamer Mahmoud¹,Gemignani Mary L.¹,Heerdt Alexandra¹,Kirstein Laurie¹,Moo Tracy-Ann¹,Pilewskie Melissa¹,Plitas George¹,Sacchini Virgilio¹,Sclafani Lisa¹,Tadros Audree¹,Van Zee Kimberly J.¹,Morrow Monica¹

Affiliation:

1. Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York

2. Biostatistical Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York

3. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2784609/jamaoncology_barrio_2021_br_210014_1639155169.59965.pdf

Reference15 articles.

1. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.;Boughey;JAMA,2013